Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mario Karolyi and Bernd Jilma.
Mario Karolyi
Connection Strength
0.637
Bernd Jilma
  1. High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19. Front Pharmacol. 2021; 12:704767.
    View in: PubMed
    Score: 0.238
  2. Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort. Wien Klin Wochenschr. 2021 Apr; 133(7-8):284-291.
    View in: PubMed
    Score: 0.224
  3. Correction to: COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 2021 Oct; 49(5):917.
    View in: PubMed
    Score: 0.061
  4. COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 2021 Oct; 49(5):907-916.
    View in: PubMed
    Score: 0.059
  5. Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19). Ann Intern Med. 2020 10 20; 173(8):670-672.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.